Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source-Reference-Cited by-同舟云学术

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source

Published:2017-09 Issue:9 Volume:48 Page:2480-2487
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Amarenco Pierre¹,Albers Gregory W.¹,Denison Hans¹,Easton J. Donald¹,Evans Scott R.¹,Held Peter¹,Hill Michael D.¹,Jonasson Jenny¹,Kasner Scott E.¹,Ladenvall Per¹,Minematsu Kazuo¹,Molina Carlos A.¹,Wang Yongjun¹,Wong K.S. Lawrence¹,Johnston S. Claiborne¹

Affiliation:

1. From the Department of Neurology and Stroke Center, Bichat University Hospital and Paris-Diderot, Sorbonne University, Paris, France (P.A.); Stanford University Medical Center, Stanford Stroke Center, Palo Alto, CA (G.W.A.); AstraZeneca, Gothenburg, Sweden (H.D., P.H., J.J., P.L.); Department of Neurology, University of California San Francisco (J.D.E.); Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA (S.R.E.); Department of Clinical Neurosciences, Hotchkiss Brain...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference22 articles.

1. Infarcts of undetermined cause: The NINCDS stroke data bank

2. Cryptogenic Stroke

3. Underlying Pathology of Stroke of Unknown Cause (Cryptogenic Stroke)

4. The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke

5. Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke;Expert Opinion on Pharmacotherapy;2024-07-02

2. From cryptogenic to ESUS: Toward precision medicine?;Revue Neurologique;2022-11

3. Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies;Current Neurology and Neuroscience Reports;2022-10-13

4. A critical assessment of the current pharmacotherapy for the treatment of embolic strokes of undetermined source;Expert Opinion on Pharmacotherapy;2022-05-06

5. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines;Stroke and Vascular Neurology;2022-04-07